David Shaw’s iRadimed IRMD Stock Holding History

David Shaw’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-18,043	Closed	-$1.74M	–	5045
2026 Q1	$1.74M	Buy	+18,043	New	+$1.8M	﹤0.01%	3022
2025 Q4	–	Sell	-10,256	Closed	-$730K	–	4795
2025 Q3	$730K	Buy	10,256 +2,393	+30%	+$159K	﹤0.01%	3654
2025 Q2	$470K	Sell	7,863 -1,289	-14%	-$70.6K	﹤0.01%	3668
2025 Q1	$480K	Sell	9,152 -3,996	-30%	-$225K	﹤0.01%	3531
2024 Q4	$723K	Sell	13,148 -2,801	-18%	-$147K	﹤0.01%	3403
2024 Q3	$802K	Buy	15,949 +7,747	+94%	+$357K	﹤0.01%	3420
2024 Q2	$360K	Buy	+8,202	New	+$349K	﹤0.01%	3800
2022 Q2	–	Sell	-11,620	Closed	-$521K	–	5534
2022 Q1	$521K	Buy	+11,620	New	+$537K	﹤0.01%	4347

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

David Shaw's IRMD Position: Q2 2026 in Review

David Shaw sold out of iRadimed (IRMD) in Q2 2026, closing a stake of 18,043 shares — an estimated $1.74M sold.

David Shaw first reported a position in IRMD in Q1 2022 and held it in 8 quarters. The position peaked at $1.74M in Q1 2026. 212 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

David Shaw reported no remaining iRadimed position as of Q2 2026 after selling out during the quarter.
David Shaw sold 18,043 iRadimed shares in Q2 2026, an estimated $1.74M.
David Shaw first reported a position in iRadimed in Q1 2022 and held it in 8 quarters.
David Shaw's iRadimed position peaked at $1.74M in Q1 2026.
212 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.